Terumo Interventional Systems offers the AZUR Peripheral HydroCoil Embolization System for the occlusion of blood vessels, vascular malformations and aneurysms, extending its interventional device portfolio.

Cheetah Medical Inc. said the FDA cleared for marketing the Reliant, a portable cardiac output monitor that provides a noninvasive window to cardiac and hemodynamic function.

MEDecision Inc. introduced Alineo, a collaborative healthcare management platform for addressing case management, disease management and utilization management.

BD Diagnostics said it received clearance from the FDA for the BD GeneOhm StaphSR assay, which the company says is the first test to rapidly and simultaneously identify two deadly healthcare-associated infections (HAIs) - Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus (MRSA) - from patients with positive blood cultures.

The FDA granted Ethicon Inc. an expanded indication for EVICEL Fibrin Sealant (Human), which is one of the first fibrin sealants available as an adjunct to hemostasis for use in surgery, when control of bleeding by standard surgical techniques is ineffective or impractical.